Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Zynlonta led to complete remission in nearly a quarter of patients with large B-cell lymphoma.
After a median follow-up of 13 months, four of the five patients had ongoing complete remission.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
An inside look at five research developments that have the potential to transform the treatment of cancer
Here are latest cancer drugs approved by the Food and Drug Administration.
The CAR-T therapy led to complete remission in 60% of people with relapsed or refractory follicular lymphoma.
Half of patients treated with Breyanzi experienced complete remission, and a majority of these responses were durable.
Umbralisib led to remission in 49% of patients with marginal zone lymphoma and 43% of those with follicular lymphoma.
More than 80% of pediatric patients experienced complete remission in a small study.
Here’s a list of the approved drugs to treat lyphoma including Non-Hodgkin lymphoma and Hodgkin lymphoma. Click on any of the medicat...
In a new website post, he provided an update on his treatment, thoughts on the U.S. and a new song.
Those with blood cancers are nine times more likely to be hospitalized or die from the flu.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.